Digestive Disease Week 2004. Bowel inflammation.
Gotham
Sue
S
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. sue.gotham@thomson.com
D001381:Azepines / Q000627:therapeutic use; D018678:Cholinergic Agents / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007546:Isoquinolines / Q000627:therapeutic use; D011724:Pyridazines / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D001381:Azepines; D018678:Cholinergic Agents; D007166:Immunosuppressive Agents; D007546:Isoquinolines; D011724:Pyridazines; D013844:Thiazoles; C476331:pralnacasan; C108965:tetomilast; D016559:Tacrolimus